Company intelligence / Profile preview

Immunology Research Institute in Gifu

Gifu, Gifu Prefecture, Japanigy-research.com ↗

Ownership: Private
Development stage: Commercial

Overview

IRIG has over 30 years of experience pioneering chicken egg antibody (IgY) technology. The institute has developed many patented IgY applications against different pathogens for use in human healthcare as well as animal and pet health. Their research has led to practical products that provide passive immunity by harnessing antibodies produced by chickens exposed to specific pathogens[1][2].

Therapeutic areas: OtherInfectious Diseases
Modalities: Chicken egg antibody (IgY) technologyAntibody
Industry: Biotech

Drug pipeline

11 assets

anti-Porphyromonas gingivalis IgY

Preclinical

10 more assets in the full pipeline.

Request access →

Partnerships

Joint research projects with universities and research institutes in Japan and overseas

Beyond the preview

Go deeper on Immunology Research Institute in Gifu.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunology Research Institute in Gifu.

Explore the full profile